These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28292536)

  • 21. Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.
    Alvarado-Castillo B; Santa Cruz-Pavlovich FJ; Gonzalez-Castillo C; Vidal-Paredes IA; Garcia-Benavides L; Rosales-Gradilla ME; Navarro-Partida J
    BMC Ophthalmol; 2023 Jul; 23(1):335. PubMed ID: 37501105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Topical interferon alpha 2 beta therapy in the management of conjunctival intraepithelial neoplasia].
    Albornoz López R; Fernández García MI; Pérez Rodrigo I
    Farm Hosp; 2007; 31(6):382-4. PubMed ID: 18348671
    [No Abstract]   [Full Text] [Related]  

  • 23. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interferon alfa-2b treatment in selected cases of recurrent conjunctival intraepithelial neoplasia].
    Toledano Fernández N; García Sáenz S; Díaz Valle D; Arteaga Sánchez A; Segura Bedmar M; Lorenzo Giménez S; Cortés Lambea L
    Arch Soc Esp Oftalmol; 2003 May; 78(5):265-71. PubMed ID: 12789630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive treatment with interferon alpha-2b may decrease the risk of papilloma-associated conjunctival intraepithelial neoplasm recurrence.
    Chen HC; Chang SW; Huang SF
    Cornea; 2004 Oct; 23(7):726-9. PubMed ID: 15448502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia.
    Huerva V; Sánchez MC; Mangues I
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):143-5. PubMed ID: 17444802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.
    Kanaya R; Kase S; Ishijima K; Ishida S
    In Vivo; 2019; 33(6):2211-2215. PubMed ID: 31662558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Sinha B; Kumar R
    Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
    Chaparro Tapias TA; Díaz Díaz AL; Secondi R; Coy Villamil H; Sánchez España JC
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov; 93(11):558-561. PubMed ID: 30072188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
    Huerva V; Mangues I
    J Fr Ophtalmol; 2008 Mar; 31(3):317-25. PubMed ID: 18404128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferon alpha 2b eyedrops as treatment of conjunctival intraepithelial neoplasia].
    Huerva V; Mangues I; Schoenenberger JA
    Farm Hosp; 2009; 33(6):335-6. PubMed ID: 20038393
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia.
    Huerva V; Mateo AJ; Mangues I; Jurjo C
    Cornea; 2006 Dec; 25(10):1220-3. PubMed ID: 17172902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma.
    Falco LA; Gruosso PJ; Skolnick K; Bejar L
    Optometry; 2007 Apr; 78(4):162-6. PubMed ID: 17400137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
    Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
    Lee JH; Kim YH; Kim MS; Kim EC
    Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advancing wavelike epitheliopathy after conjunctival intraepithelial neoplasia. Atipical case report.
    Moratal Peiro B; Calvo Garcia R; Soler Sanchis I; Mata Moret L; Cervera Taulet E
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Jun; 97(6):337-339. PubMed ID: 35676026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT; Sedeek RW; Chin KJ
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amniotic Membrane Grafting for Ocular Surface Inflammation Following Topical Interferon Alpha 2b Therapy.
    Shah SG; Mishra DK; Shah GY
    J Interferon Cytokine Res; 2022 Mar; 42(3):137-139. PubMed ID: 35298286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Topical interferon alfa-2b or surgical excision for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
    Huerva V
    Arch Soc Esp Oftalmol; 2009 Jan; 84(1):5-6. PubMed ID: 19173133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.